FCGR3A and COVID-19: Differential expression of NK cell receptor genes, such as KLRC2 and KIR3DL2 in CD16+ CD8+ TEMRA-2 cells in mild COVID-19 compared with severe COVID-19 further strengthened the hypothesis of profound differences in NK-like differentiation between disease conditions.